ClinicalTrials.Veeva

Menu
I

Intrepid Research | Cincinnati, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pitolisant
TAK-861
JZP-258
Lemborexant
Lorundrostat
TAK-994
Mazindol
Atomoxetine
AD504
High-Sodium Oxybate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 36 total trials

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients with Idiopathic Hypersomnia

The primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) wh...

Active, not recruiting
Idiopathic Hypersomnia
Excessive Daytime Sleepiness
Drug: Pitolisant

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime...

Active, not recruiting
Narcolepsy Type 1 (NT1)
Drug: Active Comparator Placebo
Drug: E2086 Placebo

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only
OSA
Drug: Aroxybutynin and Atomoxetine

This study intends to examine the utility of a home-use EEG-based sleep monitor for the diagnosis and evaluation of disorders of excessive sleepiness...

Enrolling
Sleep Disorder
Narcolepsy Type 1
Device: Dreem 3S recording

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Invitation-only
Hypertension
Drug: lorundrostat
Drug: Placebo

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Active, not recruiting
Obstructive Sleep Apnea
Drug: Acetazolamide
Drug: IHL-42X Low Dose

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a centra...

Invitation-only
Sleep Apnea
Drug: SASS-001
Drug: Placebo

Trial sponsors

Takeda logo
Jazz Pharmaceuticals logo
Apnimed logo
Eisai logo
H
M
N
Axsome Therapeutics logo
B
Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems